Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
The company acquired Everyday Health in December.
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
The search-engine giant says that one in 20 online searches are related to healthcare, and more users are using mobile to consume media.
How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy
J&J in talks to buy Actelion; Novo Nordisk pulls ads on Breitbart News; Takeda to market Ninlaro in Europe
Drugmakers can do a better job of organizing dosing information, safety information, and clinical data on their brand websites, a new survey found.
Merck Consumer Health CMO Atilla Cansun also talks about about why the company is focused on preparing society for an average lifespan of 100 years.
GlaxoSmithKline's campaign goal was to educate grandparents (particularly first-time grandparents) and parents about the serious nature of whooping cough.
"Standard economic concerns like price elasticity fall out of the equation when people simply have no choices. No one buys an EpiPen for fun," Dr. David Katz writes.
For years the social network has been telling advertisers they must pay to magnify their exposure, but most continue to resist.
Drugmakers routinely pay ghostwriters to write industry-funded research articles; Horizon to buy Raptor for $800 million; WellDoc partners with J&J
The vice president of audience development talks about her days in the dot-com world and how struggling in a new role shaped her career.
Remedy Health, taking a cue from Humans of New York, offers snapshots of patients' stories.
Such intense interest in health content is a rich opportunity to engage, inform, support, and motivate key customer constituencies.
Verywell.com presents physician-reviewed health and wellness content that aims to be "gentler" than other health websites.
Analyst survey says docs want outcomes benefit from PCSK9s; Allergan licenses early-stage Alzheimer's drugs; Pfizer and IBM partner in Parkinson's disease
Pfizer and Allergan call off merger; the FDA approves second biosimilar; NEJM comes under fire
WPP's acquisition of CMI, a significant player in the healthcare media-planning space, will likely bolster the services it provides to pharma clients.
Sandor Marik, previously of Business Insider and Condé Nast, will lead the publisher's marketing and audience development strategy.
They will attempt to develop a new industry standard for digital advertising viewability, a much debated topic that has vexed the broader advertising industry.
Rick Berke, executive editor of Stat, talks about the title's strategy to make health, medicine and life sciences content compelling and deliver this news to a general audience.
Social listening can help all along the value chain—from research and discovery to developing marketing plans and strategy.
Negative news coverage of statins may lead people to stop taking their medication; second patient dies in Zafgen obesity drug trial; Gilead defends pricing
Interpublic's dedicated group extended its brief beyond North America.
Company's vaccines chief credits campaigns aimed at grownups with driving US demand for blockbuster vaccine. The remaining cohort will be harder to capture.
Test your knowledge in this week's edition of the MM&M Weekly News Quiz
Theranos posted the lengthy response on the news section of its website on Thursday, then bragged on Twitter that its statement was 3,000 words longer than the WSJ story.
This year's inductees are C.Marshall Paul and Scott Cotherman. Ken Begasse Sr. will receive the 2016 Lifetime Achievement Award.
Test your knowledge in this week's edition of the MM&M Weekly News Quiz.